Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$427K Buy
5,941
+1,243
+26% +$117K 0.2% 61
2026
Q1
$555K Buy
4,698
+102
+2% +$12.6K 0.29% 52
2025
Q4
$578K Sell
4,596
-2,795
-38% -$365K 0.29% 57
2025
Q3
$1.08M Sell
7,391
-749
-9% -$113K 0.54% 45
2025
Q2
$1.27M Buy
8,140
+51
+0.6% +$8.09K 0.69% 45
2025
Q1
$1.33M Sell
8,089
-434
-5% -$72.2K 0.75% 43
2024
Q4
$1.39M Hold
8,523
0.74% 40
2024
Q3
$1.67M Buy
8,523
+71
+0.8% +$13.1K 0.84% 39
2024
Q2
$1.47M Buy
8,452
+2,910
+53% +$484K 0.79% 41
2024
Q1
$938K Buy
5,542
+1,051
+23% +$197K 0.48% 53
2023
Q4
$886K Hold
4,491
0.48% 53
2023
Q3
$781K Buy
4,491
+101
+2% +$18.3K 0.47% 52
2023
Q2
$756K Buy
4,390
+50
+1% +$8.64K 0.43% 53
2023
Q1
$722K Buy
+4,340
New +$711K 0.41% 54
2022
Q2
Sell
-220
Closed -$41K 108
2022
Q1
$41K Sell
220
-66
-23% -$13K 0.02% 97
2021
Q4
$70K Buy
286
+66
+30% +$14.5K 0.03% 95
2021
Q3
$43K Hold
220
0.02% 95
2021
Q2
$41K Hold
220
0.02% 98
2021
Q1
$35K Hold
220
0.02% 94
2020
Q4
$36K Hold
220
0.02% 91
2020
Q3
$36K Hold
220
0.03% 89
2020
Q2
$30K Buy
+220
New +$28.7K 0.02% 91
2016
Q2
Sell
-80,920
Closed -$3.59M 108
2016
Q1
$3.59M Sell
80,920
-1,045
-1% -$44.3K 2.82% 14
2015
Q4
$3.93M Sell
81,965
-975
-1% -$44.1K 3.18% 11
2015
Q3
$3.42M Sell
82,940
-2,205
-3% -$102K 2.83% 14
2015
Q2
$4.11M Sell
85,145
-1,035
-1% -$49.4K 2.94% 19
2015
Q1
$3.99M Sell
86,180
-1,100
-1% -$49.6K 2.75% 20
2014
Q4
$3.76M Buy
+87,280
New +$3.54M 2.51% 23

Other funds holding ZTS

Lipe & Dalton's ZTS Position: Q2 2026 in Review

Lipe & Dalton increased its Zoetis (ZTS) stake by 26% in Q2 2026, buying an estimated $117K and bringing the position to 5,941 shares worth $427K. The position accounts for 0.2% of the portfolio, ranked #61.

Lipe & Dalton first reported a position in ZTS in Q4 2014 and has held it in 28 quarters since. The position peaked at $4.11M in Q2 2015. 590 funds tracked by Wall St. Rank hold ZTS as of Q2 2026.

  • Lipe & Dalton held 5,941 shares of Zoetis worth $427K as of Q2 2026.
  • Lipe & Dalton bought 1,243 Zoetis shares in Q2 2026, an estimated $117K.
  • Zoetis made up 0.2% of Lipe & Dalton's portfolio in Q2 2026, its #61 holding.
  • Lipe & Dalton first reported a position in Zoetis in Q4 2014 and has held it in 28 quarters since.
  • Lipe & Dalton's Zoetis position peaked at $4.11M in Q2 2015.
  • 590 funds tracked by Wall St. Rank held Zoetis as of Q2 2026.

Based on Lipe & Dalton's 13F filing for Q2 2026, filed 14 Jul 2026.